The company “has received tentative approval from the United States Food and Drug Administration (USFDA) for Sugammadex injection, 200 mg/2 mL (100 mg/mL) and 500 mg/5 mL (100 mg/mL) single-dose vial…”, Gland Pharma said in a regulatory filing.
Copyright © 2024 | WordPress Theme by MH Themes